CollPlant Biotechnologies (CLGN) to Release Quarterly Earnings on Wednesday

CollPlant Biotechnologies (NASDAQ:CLGN) will likely be posting its quarterly earnings results before the market opens on Wednesday, March 26th. Analysts expect CollPlant Biotechnologies to post earnings of ($0.42) per share and revenue of $0.36 million for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

CollPlant Biotechnologies Stock Performance

Shares of NASDAQ CLGN opened at $3.24 on Monday. CollPlant Biotechnologies has a fifty-two week low of $3.00 and a fifty-two week high of $6.75. The firm has a market capitalization of $37.06 million, a PE ratio of -2.10 and a beta of 1.07. The stock’s 50-day simple moving average is $3.57 and its 200-day simple moving average is $4.00.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. HC Wainwright reissued a “buy” rating and set a $11.00 target price on shares of CollPlant Biotechnologies in a research report on Friday, November 29th. D. Boral Capital reaffirmed a “buy” rating and set a $14.00 price target on shares of CollPlant Biotechnologies in a research report on Wednesday, February 12th.

CollPlant Biotechnologies Company Profile

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology.